What is Assembly Biosciences's cash ratio?

Assembly Biosciences (ASMB) reported cash ratio of 0.9× in Q1 2026.

How has Assembly Biosciences's cash ratio changed year-over-year?

Assembly Biosciences's cash ratio increased by 77.1% year-over-year, from 0.5× to 0.9×.

What is the long-term trend for Assembly Biosciences's cash ratio?

Over 5 years (2020 to 2025), Assembly Biosciences's cash ratio has grown at a -13.2% compound annual growth rate (CAGR), from 2.4× to 1.2×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Assembly Biosciences ASMB Cash ratio

Cash ratio at other companies

Arrowhead ResearchARWR

0.6×-0.2×

ALN

Alnylam PharmaceuticalsALNY

1.3×+0.3×

Avalo TherapeuticsAVTX

2.2×-20.1×

Arbutus Biopharma CorporationABUS

4.6×+2.7×

Vir Biotechnology, Inc.VIR

3.8×+1.2×

Maravai LifeSciences Holdings, Inc.MRVI

3.9×-0.6×

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Calculated from Assembly Biosciences’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's cash ratio?: Assembly Biosciences (ASMB) reported cash ratio of 0.9× in Q1 2026.
How has Assembly Biosciences's cash ratio changed year-over-year?: Assembly Biosciences's cash ratio increased by 77.1% year-over-year, from 0.5× to 0.9×.
What is the long-term trend for Assembly Biosciences's cash ratio?: Over 5 years (2020 to 2025), Assembly Biosciences's cash ratio has grown at a -13.2% compound annual growth rate (CAGR), from 2.4× to 1.2×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.